Table 3.
Group A (n = 254) | Group B (n = 307) | P value | |
Metachronous HNSCC | |||
No. of patients | 10 (3.9) | 30 (9.8) | 0.008 |
No. of lesions per patients | 0.404 | ||
1 | 9 | 22 | |
≥ 2 | 1 | 8 | |
Total number of cancers | 11 | 53 | 0.007 |
Location of cancer | |||
Oropharynx | 3 | 13 | |
Hypopharynx | 7 | 34 | |
Larynx | 1 | 6 | |
Clinical stage | < 0.001 | ||
I/II | 4 (36) | 53 (100) | |
III/IV | 7 (64) | 0 | |
Interval between ESCC and HNSCC | |||
Median months (range) | 56 (7-80) | 31 (7-107) | 0.130 |
HNSCC: Head and neck squamous cell carcinoma.